Literature DB >> 34848849

Fetal-neonatal neurology program development: Continuum of care during the first 1000 days.

Sonika Agarwal1, Mark S Scher2.   

Abstract

Global estimates show that 10-20% of persons express developmental disability. During critical and sensitive periods of developmental neuroplasticity over the first 1000 days, adverse gene-environment interactions are likely to contribute to permanent life-long disabilities and early mortality. This article describes fetal-neonatal neurology (FNN) program development that integrates vertical and horizontal diagnostic perspectives. Trimester-specific conditions to the maternal-placental-fetal triad begin at conception, followed by pediatric patient care over the first two years of life to address changing phenotypic form and function. While fetal and neonatal neurology trainees prepare to offer person-centric healthcare, population-based considerations address obstacles to optimal health relevant to resource-rich and poor nations. Maternal and pediatric care practices over the first 1000 days underscore equitable health policy. Global initiatives apply geographic distance, biosocial dynamics, and cultural differences to developmental origins and life-course theories, to more effectively reduce disease burden over the life continuum.
© 2021. The Author(s), under exclusive licence to Springer Nature America, Inc.

Entities:  

Mesh:

Year:  2021        PMID: 34848849     DOI: 10.1038/s41372-021-01282-5

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  13 in total

1.  The great obstetrical syndromes.

Authors:  Gian Carlo Di Renzo
Journal:  J Matern Fetal Neonatal Med       Date:  2009-08

2.  Training in Fetal-Neonatal Neurology: Principles to Guide Practice for Career-Long Learning.

Authors:  Mark Scher
Journal:  Pediatr Neurol       Date:  2016-10-11       Impact factor: 3.372

3.  Sampling and Definitions of Placental Lesions: Amsterdam Placental Workshop Group Consensus Statement.

Authors:  T Yee Khong; Eoghan E Mooney; Ilana Ariel; Nathalie C M Balmus; Theonia K Boyd; Marie-Anne Brundler; Hayley Derricott; Margaret J Evans; Ona M Faye-Petersen; John E Gillan; Alex E P Heazell; Debra S Heller; Suzanne M Jacques; Sarah Keating; Peter Kelehan; Ann Maes; Eileen M McKay; Terry K Morgan; Peter G J Nikkels; W Tony Parks; Raymond W Redline; Irene Scheimberg; Mirthe H Schoots; Neil J Sebire; Albert Timmer; Gitta Turowski; J Patrick van der Voorn; Ineke van Lijnschoten; Sanne J Gordijn
Journal:  Arch Pathol Lab Med       Date:  2016-05-25       Impact factor: 5.534

4.  Communication Challenges in Neonatal Encephalopathy.

Authors:  Monica E Lemmon; Pamela K Donohue; Charlamaine Parkinson; Frances J Northington; Renee D Boss
Journal:  Pediatrics       Date:  2016-08-03       Impact factor: 7.124

Review 5.  Neurologic outcome after fetal inflammatory response syndrome: Trimester-specific considerations.

Authors:  Mark S Scher
Journal:  Semin Fetal Neonatal Med       Date:  2020-07-04       Impact factor: 3.926

Review 6.  Fellowship Training in the Emerging Fields of Fetal-Neonatal Neurology and Neonatal Neurocritical Care.

Authors:  Christopher D Smyser; Emily W Y Tam; Taeun Chang; Janet S Soul; Steven P Miller; Hannah C Glass
Journal:  Pediatr Neurol       Date:  2016-06-25       Impact factor: 3.372

Review 7.  Principles of plasticity in the developing brain.

Authors:  Bryan Kolb; Allonna Harker; Robbin Gibb
Journal:  Dev Med Child Neurol       Date:  2017-09-13       Impact factor: 5.449

8.  Quantifying disability: data, methods and results.

Authors:  C J Murray; A D Lopez
Journal:  Bull World Health Organ       Date:  1994       Impact factor: 9.408

9.  Parent Experience of Neonatal Encephalopathy.

Authors:  Monica E Lemmon; Pamela K Donohue; Charlamaine Parkinson; Frances J Northington; Renee D Boss
Journal:  J Child Neurol       Date:  2016-12-08       Impact factor: 1.987

Review 10.  Cerebral plasticity: Windows of opportunity in the developing brain.

Authors:  Fatima Yousif Ismail; Ali Fatemi; Michael V Johnston
Journal:  Eur J Paediatr Neurol       Date:  2016-08-09       Impact factor: 3.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.